Blue Earth Diagnostics
Clinical trials sponsored by Blue Earth Diagnostics, explained in plain language.
-
New imaging agent shows promise for spotting prostate cancer
Diagnosis CompletedThis early-stage study tested a new radioactive imaging agent, rhPSMA-7.3 (18F), in 24 people—some healthy and some with prostate cancer. The goal was to see if it is safe and can help doctors see prostate cancer on scans. The study focused on safety and how the agent spreads thr…
Phase: PHASE1 • Sponsor: Blue Earth Diagnostics • Aim: Diagnosis
Last updated May 26, 2026 12:06 UTC
-
Which PET scan is better at spotting hidden prostate cancer?
Diagnosis CompletedThis study involved 62 men whose prostate cancer had returned after surgery, shown by a small rise in PSA levels. Researchers compared two types of PET scans to see which one had less urine activity in the bladder, which can hide cancer spots. The goal was to find which scan migh…
Phase: PHASE4 • Sponsor: Blue Earth Diagnostics • Aim: Diagnosis
Last updated May 26, 2026 12:05 UTC
-
New scan spots hidden prostate cancer return
Diagnosis CompletedThis study tested a new type of PET scan (rhPSMA 7.3) to see if it can safely and accurately find prostate cancer that has come back in men with rising PSA levels after initial treatment. 391 men with suspected recurrence received the scan, and doctors checked if the scan correct…
Phase: PHASE3 • Sponsor: Blue Earth Diagnostics • Aim: Diagnosis
Last updated May 26, 2026 12:03 UTC